Cyclic changes in the matrix metalloproteinase system in the ovary and uterus

Biology of Reproduction

Volumn 64, Issue 5, 2001, Pages 1285-1296

  Curry T E , Jr ^a   Osteen, K G ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

Menstrual cycle; Ovary ovulation; Steroid hormones; Uterus

Indexed keywords

MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR;

CORPUS LUTEUM FUNCTION; EXTRACELLULAR MATRIX; HUMAN; LUTEOLYSIS; MENSTRUAL CYCLE; OOCYTE; OVARY; OVARY FOLLICLE CELL; OVULATION; PRIORITY JOURNAL; SHORT SURVEY; UTERUS;

EID: 0035032124     PISSN: 00063363     EISSN: None     Source Type: Journal    
DOI: 10.1095/biolreprod64.5.1285     Document Type: Short Survey

References (147)

1. Matrix metalloproteinases: A review
2. Matrix metalloproteinases
3. Evaluation of some newer matrix metalloproteinases
4. Structural biochemistry and activation of matrix metalloproteases
5. Tissue inhibitors of metalloproteinases: Structure, regulation and biological functions
6. Tissue inhibitors of metalloproteinases: Evolution, structure and function
7. 2-macroglobulin in rat ovarian follicles and corpora lutea
8. 2-macroglobulin gene in rat ovarian granulosa cells: Stat 5 activation and binding to the interleukin-6 response element
9. Tissue inhibitor of metalloproteinase (TIMP-2). A new member of the metalloproteinase inhibitor family
10. Differential regulation of TIMP-1 and TIMP-2 mRNA expression in normal and Ha-ras-transformed murine fibroblasts
11. A new inhibitor of metalloproteinases from chicken: ChIMP-3. A third member of the TIMP family
12. Tissue inhibitor of metalloproteinases-3 (TIMP-3) is an extracellular matrix-associated protein with a distinctive pattern of expression in mouse cells and tissues
13. Murine tissue inhibitor of metalloproteinases-4 (Timp-4): cDNA isolation and expression in adult mouse tissues
14. Tissue inhibitor of metalloproteinases (TIMP-1) produced by granulosa and oviduct cells enhances in vitro development of bovine embryo
15. Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity
16. Tissue inhibitor of metalloproteinases from human bone marrow stromal cell line KM 102 has erythroid potentiating activity, suggesting its possibly bifunctional role in the hematopoietic environment
17. Tissue inhibitor of metalloproteinase-2 (TIMP-2) has erythroid-potentiating activity
18. Tissue inhibitor of metalloproteinases-2 inhibits bFGF-induced human microvascular endothelial cell proliferation
19. Inhibition of angiogenesis by tissue inhibitor of metalloproteinase
20. Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells: A possible new growth factor in serum
21. Coordinated expression of extracellular-matrix-degrading proteinases and their inhibitors regulates mammary epithelial function during involution
22. A novel member of human tissue inhibitor of metalloproteinases (TIMP) gene family is regulated during G1 progression, mitogenic stimulation, differentiation, and senescence
23. Tissue inhibitor of metalloproteinase-1 (TIMP-1) binds to the cell surface and translocates to the nucleus of human MCF-7 breast carcinoma cells
24. Identification of a stimulator of steroid hormone synthesis isolated from testis
25. Assessment of the role of tissue inhibitor of metalloproteinase-1 (TIMP-1) during the periovulatory period in female mice lacking a functional TIMP-1 gene
26. Disruption of the tissue inhibitor of metalloproteinase-1 gene results in altered reproductive cyclicity and uterine morphology in reproductive-age female mice
27. Follicular development and its control
28. Follicular growth and ovarian dynamics in mammals
29. Differential distribution of gelatinases and tissue inhibitor of metalloproteinase-1 in the rat ovary
30. Collagenase and gelatinase messenger ribonucleic acid expression and activity during follicular development in the rat ovary
31. Metalloproteinase activity during growth, maturation and atresia in the ovarian follicles of the goat
32. Chronology of events accompanying follicular atresia in hypophysectomized ewes. Changes in levels of steroidogenic enzymes, connexin 43, insulin-like growth factor II mannose 6 phosphate receptor, extracellular matrix components, and matrix metalloproteinases
33. Hormonal regulation of tissue inhibitors of metalloproteinases during follicular development in the rat ovary
34. Production of gelatinases and tissue inhibitors of matrix metalloproteinases by equine ovarian stromal cells in vitro
35. Characterization of bovine ovarian surface epithelium and stromal cells: Identification of secreted proteins
36. Growth factors and extracellular matrix proteins in interactions of cumulus-oocyte complex, spermatozoa and oviduct
37. Effect of immunization against the amino-terminal peptide (alpha N) of the alpha 43-subunit of inhibin on follicular atresia and expression of tissue inhibitor of matrix metalloproteinase (TIMP-1) in ovarian follicles of sheep
38. Ovulation
39. Ovulation and the mechanism of follicle rupture. VI. Ultrastructure of theca interna and the inner vascular network surrounding rabbit graafian follicles prior to induced ovulation
40. Ovulation and the mechanism of follicle rupture. V. Ultrastructure of tunica albuginea and theca externa of rabbit graafian follicles prior to induced ovulation
41. Collagen, collagenase and collagenolytic activity in rat graafian follicles during follicular growth and ovulation
42. Enhanced degradation of collagen within apical vs. basal wall of ovulatory ovine follicle
43. Collagenolytic enzyme activity in human ovary: An ovulatory enzyme system
44. The extraction of a tissue collagenase associated with ovulation in the rat
45. The involvement of collagenolysis in ovulation in the rat
46. Preovulatory changes in ovarian expression of collagenases and tissue metalloproteinase inhibitor messenger ribonucleic acid: Role of eicosanoids
47. Gelatinase and proteoglycanase activity during the periovulatory period in the rat
48. Regulation and localization of matrix metalloproteinases and tissue inhibitors of metalloproteinases in the mouse ovary during gonadotropin-induced ovulation
49. Interactive roles of progesterone, prostaglandins, and collagenase in the ovulatory mechanism of the ewe
50. Expression of matrix metalloproteinases and their tissue inhibitor messenger ribonucleic acids in Macaque periovulatory granulosa cells: Time course and steroid regulation
51. The preovulatory increase in ovarian collagenase activity in the rat is independent of prostaglandin production
52. Type IV collagenolytic activity in human preovulatory follicular fluid
53. Luteinization and proteolysis in ovarian follicles of Meishan and Large White gilts during the preovulatory period
54. Blockage of ovulation in the explanted hamster ovary by a collagenase inhibitor
55. Inhibitors of mammalian tissue collagenase and metalloproteinases suppress ovulation in the perfused rat ovary
56. Temporal and spatial expression of tissue inhibitors of metalloproteinases during the natural ovulatory cycle of the mouse
57. Hormonal regulation of matrix metalloproteinase inhibitors in rat granulosa cells and ovaries
58. Regulation of granulosa cell-derived ovarian metalloproteinase inhibitor(s) by prolactin
59. Molecular cloning of an ovine ovarian tissue inhibitor of metalloproteinases: Ontogeny of messenger ribonucleic acid expression and in situ localization within preovulatory follicles and luteal tissue
60. A tissue inhibitor of metalloproteinases and α-macroglobulins in the ovulating rat ovary: Possible regulators of collagen matrix breakdown
61. Role of protein synthesis, prostaglandins, and estrogen in rat ovarian metalloproteinase inhibitor production
62. Ontogenies of messenger RNA encoding tissue inhibitor of metalloproteinases 1 and 2 within bovine periovulatory follicles and luteal tissue
63. Changes in ovarian TIMP expression during follicular growth, ovulation, and the luteal period in the rat
64. Expression of messenger ribonucleic acid encoding tissue inhibitor of metalloproteinases-2 within ovine follicles and corpora lutea
65. The regulation of the mammalian corpus luteum
66. Mechanisms associated with corpus luteum development
67. The corpus luteum and its Control in infraprimate species
68. The human corpus luteum: Remodelling during luteolysis and maternal recognition of pregnancy
69. Cellular mechanisms involved in luteolysis
70. Formation of ovarian cysts in aged irregularly cycling rats
71. Control of the luteal function in humans
72. Immune regulation of corpus luteum function
73. Collagenase, gelatinase, and proteoglycanase mRNA expression and activity during luteal development, maintenance, and regression in the pseudopregnant rat ovary
74. Distinct expression of gelatinase A [matrix metalloproteinase (MMP)-2], collagenase-3 (MMP-13), membrane type MMP 1 (MMP-14), and tissue inhibitor of MMPs type 1 mediated by physiological signals during formation and regression of the rat corpus luteum
75. Identification of matrix metalloproteinases and metalloproteinase inhibitors in bovine corpora lutea and their variation during the estrous cycle
76. The effect of luteal "rescue" on the expression and localization of matrix metalloproteinases and their tissue inhibitors in the human corpus luteum
77. Coordinate induction and activation of metalloproteinase and ascorbate depletion in structural luteolysis
78. Temporal expression of tissue inhibitors of metalloproteinases in mouse reproductive tissues during gestation
79. Developmental expression of tissue inhibitor of metalloproteinase (TIMP) RNA
80. Expression and activity of ovarian tissue inhibitors of metalloproteinases during pseudopregnancy in the rat
81. mRNA of bovine tissue inhibitor of metalloproteinase: Sequence and expression in bovine ovarian tissue
82. Bovine granulosa cells express extracellular matrix proteins and their regulators during luteinization in culture
83. Expression of tissue inhibitor of metalloproteinases-1 in the human corpus luteum after luteal rescue
84. Immunolocalization of tissue inhibitor of metalloproteinases within ovine periovulatory follicular and luteal tissues
85. Pattern of protein production by bovine corpora lutea during luteolysis and characterization of expression of two major secretory products of regressing corpora lutea
86. Expression of tissue inhibitor of metalloproteinases-1 in the primate ovary during induced luteal regression
87. Coordinate expression of matrix metalloproteinase family members in the uterus of normal, matrilysin-deficient, and stromelysin-1-deficient mice
88. Regulation of matrilysin in the rat uterus
89. Activity of 72-kDa and 92-kDa matrix metalloproteinases in placental tissues of cows with and without retained fetal membranes
90. Matrix metalloproteinases and their tissue inhibitors at the ovine trophoblast-uterine interface
91. Matrix metalloproteinases as mediators of reproductive function
92. An epithelial matrix metalloproteinase with potentially novel functions
93. Expression and localization of matrilysin, a matrix metalloproteinase, in human endometrium during the reproductive cycle
94. Matrix metalloproteinase expression in Macaca mulatta endometrium: Evidence for zone-specific regulatory tissue gradients
95. Focal cellular origin and regulation of interstitial collagenase (matrix metalloproteinase-1) are related to menstrual breakdown in the human endometrium
96. Matrix metalloproteinase production by cultured human endometrial stromal cells: Identification of interstitial collagenase, gelatinase-A, gelatinase-B, and stromelysin-1 and their differential regulation by interleukin-1a and tumor necrosis factor-a
97. Patterns of matrix metalloproteinase expression in cycling endometrium imply differential functions and regulation by steroid hormones
98. Growth factors and growth modulators in human uterine endometrium: Their potential relevance to reproductive medicine
99. Cytokine expression in human endometrium throughout the menstrual cycle
100. Paracrine regulation of matrix metalloproteinase expression in normal human endometrium
101. Integrin switching regulates normal trophoblast invasion
102. Adhesive interactions in peri-implantation morphogenesis and placentation
103. Regulation of apoptosis during development: Input from the extracellular matrix
104. Embryo implantation and tumor metastasis: Common pathways of invasion and angiogenesis
105. Stromal-epithelial interaction mediates steroidal regulation of matrix metalloproteinase expression in the human placenta
106. Ovarian steroid-modulated stromelysin-1 expression in human endometrial stromal and decidual cells
107. Cytokine-mediated regulation of 92-kilodalton type IV collagenase, tissue inhibitor of metalloproteinase-1 (TIMP-1), and TIMP-3 messenger ribonucleic acid expression in human endometrial stromal cells
108. Matrix metalloproteinase and matrix metalloproteinase inhibitor expression in endometrial stromal cells during progestin-initiated decidualization and menstruation-related progestin withdrawal
109. Progesterone regulates the activity of collagenase and related gelatinases A and B in human endometrial explants
110. Secretion of matrix metalloproteinases by human endometrial cells in vitro
111. Metalloproteinase expression and hormonal regulation during tissue remodeling in the cycling human endometrium
112. Transforming growth factor-beta mediates the progesterone suppression of an epithelial metalloproteinase by adjacent stroma
113. Local cytokines induce differential expression of matrix metalloproteinases but not their tissue inhibitors in human endometrial fibroblasts
114. Progesterone exposure prevents matrix metalloproteinase-3 (MMP-3) stimulation by interleukin-1α in human endometrial stromal cells
115. Tissue inhibitor of metalloproteinases (TIMP)-1, -2 and -3 in human endometrium during the menstrual cycle
116. A biological model for the regulation of peri-implantational hemostasis and menstruation
117. Production of endometrial matrix metalloproteinases, but not their tissue inhibitors, is modulated by progesterone withdrawal in an in vitro model for menstruation
118. Degradation of extracellular matrix by the trophoblastic cells of first-trimester human placentas
119. Adhesive and degradative properties of human placental cytotrophoblast cell in vitro
120. Simultaneous expression of 70 kilodalton type IV collagenase and type IV collagen al (IV) chain genes by cells of early human placenta and gestational endometrium
121. Co-ordinated expression of MMP-2 and its putative activator, MT1-MMP, in human placentation
122. Identification of 72-kilodalton type IV collagenase at sites of trophoblastic invasion of macaque spiral arteries
123. mRNA expressions of TIMP-1, -2, -3, and 92-KD type IV collagenase in early human placenta and decidual membrane as studied by in situ hybridization
124. Expression of stromelysin-3 in the human placenta and placental bed
125. Proteolytic activity of first trimester human placenta: Localization of interstitial collagenase in villous and extravillous trophoblast
126. Membrane-type matrix metalloproteinase-1 expression at the site of human placentation
127. Detection of mRNA's encoding collagenase I and stromelysin 2 in carcinomas of the head and neck by in situ hybridization
128. An autocrine/paracrine role of human decidual relaxin. Stromelysin-I (MMP-3) and tissue inhibitor of matrix metalloproteinase 1 (TIMP-1)
129. Collagenase-1, stromelysin-1, and matrilysin are expressed within the placenta during multiple stages of human pregnancy
130. Expression of matrix metalloproteinase-2, -9, and -14, tissue inhibitors of metalloproteinase-1 and matrix proteins in human placenta during the first trimester
131. Tissue inhibitor of metaloproteinase-3 expression is up-regulated during human cytotrophoblast invasion in vitro
132. Induction of tissue inhibitor of metalloproteinase 3 gene expression during in vitro decidualization of human endometrial stromal cells
133. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in the mouse uterus during the peri-implantation period
134. Involvement of matrix metalloproteinases 2 and 9, tissue inhibitor of metalloproteinases and apoptosis in tissue remodelling in the sheep placenta
135. Effect of inhibition of matrix metalloproteinases on endometrial decidualization and implantation in mated rats
136. Interleukin-1a opposes progesterone-mediated suppression of MMP-7: A possible role of this cytokine during implantation
137. Type IV collagenase mediates invasion of human cytotrophoblasts
138. Developmental regulation of 72 kD and 92 kD type IV collagenases in human trophoblasts: A possible mechanism for control of trophoblast invasion
139. Expression of gelatinase B by trophoblast cells: Down-regulation by progesterone
140. Interleukin-1β regulates human cytotrophoblast metalloproteinase activity and invasion in vitro
141. Cytokines and embryo implantation
142. Role of endometrial factors in regulating secretion of components of the immunoreactive human embryonic interleukin-1 system during embryonic development
143. Immunocytochemical localization and changes in endometrial progestin receptor protein during the porcine estrous cycle and early pregnancy
144. Endometrial progesterone receptors and markers of uterine receptivity in the window of implantation
145. Comparative immunohistochemical study of estrogen and progesterone receptors in the fallopian tube and uterus at different stages of the menstrual cycle and the menopause
146. Temporal and spatial alterations in uterine estrogen receptor and progesterone receptor gene expression during the estrous cycle and early pregnancy in the ewe